GlassScriptPhysician profile
Tonee Gonzalez
NPI 1790560126
$1,188.82
in general payments reported to CMS, 2019-2025
9 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.53 · 2024: $789 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691 · Travel and Lodging: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.58 |
| Travel and Lodging | $498.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $710.73 | 2024 | Vasoview Hemopro 2 |
| Abiomed | $152.20 | 2025 | |
| Cardiva Medical, INC. | $147.32 | 2024-2025 | Savvywire, Optowire, Cardiva Vascade 6/7f Vcs |
| Medtronic, INC. | $62.89 | 2025 | Micra, Linq II |
| Corcym INC | $31.38 | 2024 | Perceval |
| Atricure, INC. | $24.61 | 2024 | |
| Cvrx, INC. | $22.06 | 2025 | Barostim Neo System |
| Vapotherm INC | $20.53 | 2023 | Vapotherm |
| Novo Nordisk INC | $17.10 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonee Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.